Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I data reported for PD-0332991 plus letrozole in advanced breast cancer

Dec. 28, 2009

Everolimus shows clinical activity in Waldenstrom's macroglobulinemia and myelofibrosis

Dec. 28, 2009

Clinical data on pomalidomide in myelofibrosis patients disclosed at ASH meeting

Dec. 28, 2009

Encouraging phase I data reported for TRU-016 in relapsed/refractory CLL

Dec. 28, 2009

Vadimezan added to taxane-containing regimens evaluated in mouse breast cancer models

Dec. 24, 2009

Fluticasone furoate nasal spray may be beneficial in children with otitis media

Dec. 24, 2009

GP2/GM-CSF peptide vaccine may prevent breast cancer recurrence

Dec. 24, 2009

BHQ-880 shown to be safe in combination with zoledronic acid and MM therapy

Dec. 24, 2009

TG-101348 reduces JAK2 V617F allele burden in phase I myelofibrosis trial

Dec. 24, 2009

Fusion protein ACE-435 shows promise in cancer-induced cachexia therapy

Dec. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...